PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
22.91%
Some net income increase while VUZI is negative at -6.86%. John Neff would see a short-term edge over the struggling competitor.
5.52%
Some D&A expansion while VUZI is negative at -43.30%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-38.11%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-1.59%
Negative yoy SBC while VUZI is 23.20%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
101.89%
Well above VUZI's 146.24% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-582.54%
Both yoy AR lines negative, with VUZI at -53.58%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-624.15%
Both reduce yoy inventory, with VUZI at -72.03%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
798.79%
Lower AP growth vs. VUZI's 17474.28%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-5.58%
Negative yoy usage while VUZI is 177.99%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-135.82%
Negative yoy while VUZI is 189.89%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
80.54%
Operating cash flow growth above 1.5x VUZI's 3.73%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-69.49%
Both yoy lines negative, with VUZI at -21.94%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
55.25%
Acquisition growth of 55.25% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-48.98%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
29.60%
Liquidation growth of 29.60% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-181.58%
Both yoy lines negative, with VUZI at -79.51%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-212.64%
Both yoy lines negative, with VUZI at -21.94%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
35.47%
Debt repayment growth of 35.47% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
28000.00%
Issuance growth of 28000.00% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-9.90%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.